Overview

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe treatment with candesartan cilexetil 16mg for 8 weeks, in uncontrolled hypertensive patients, in improvement of achieving of treatment goals and impact on blood pressure level in patients with uncontrolled hypertension treated with candesartan cilexetil.
Details
Lead Sponsor:
AstraZeneca
Treatments:
Candesartan
Candesartan cilexetil